183490.KQ
Enzychem Lifesciences Corporation
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 990.00
−2.65%Year over year
Reported trailing growth
- Revenue
- -12.4%
- EBITDA
- +16.4%
- EBIT
- -41.6%
- EPS
- +15.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +36.5%
- EBITDA
- +17.7%
- EBIT
- -38.5%
- Net income
- +18.0%
- EPS
- +13.1%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025